% | $
Quotes you view appear here for quick access.

PharmAthene, Inc. Message Board

  • corporaterobot corporaterobot Mar 7, 2013 4:37 PM Flag

    The recent upgrade

    Why would an analyst slap a $6 price target upon initiation of coverage when the stock is selling for less than $1.50? He could have "played it safe" and put a target of $4.

    Someone did some due diligence and some math...

    Sentiment: Buy

2.4257+0.0457(+1.92%)12:38 PMEDT